CLINICAL_TRIALS
trial_result
· 2026-01-28
Clinical Trial Update: Intravenous Nalbuphine for Prevention of Intrathecal Morphine-induced Nausea and Vomiting in Patients Undergoing Cesarean Section: A Double-blind, Randomized Controlled Trial. [NA]
Summary
A completed double-blind randomized trial evaluated intravenous nalbuphine for prevention of intrathecal morphine-induced nausea and vomiting in patients underg…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Thammasat University | Conditions: Intrathecal Morphine, Caesarean Section | NA | Status: COMPLETED